Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 3
1983 4
1984 4
1985 10
1986 3
1987 3
1988 6
1989 3
1990 9
1991 9
1992 15
1993 16
1994 15
1995 12
1996 14
1997 16
1998 14
1999 25
2000 15
2001 14
2002 14
2003 14
2004 15
2005 11
2006 8
2007 11
2008 10
2009 6
2010 3
2011 2
2012 2
2014 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

303 results
Results by year
Filters applied: . Clear all
Page 1
The effects of tibolone in older postmenopausal women
Cummings SR, et al. N Engl J Med 2008 - Clinical Trial. Among authors: Kenemans P. PMID 18703472 Free PMC article.
RESULTS: During a median of 34 months of treatment, the tibolone group, as compared with the placebo group, had a decreased risk of vertebral fracture, with 70 cases versus 126 cases per 1000 person-years (relative hazard, 0.55; 95% confidence interval [CI], 0.41 to 0.74; P<0.001), and a decreased risk of nonvertebral fracture, with 122 cases versus 166 cases per 1000 person-years (relative hazard, 0.74; 95% CI, 0.58 to 0.93; P=0.01). The tibolone group also had a decreased risk of invasive breast cancer (relative hazard, 0.32; 95% CI, 0.13 to 0.80; P=0.02) and colon cancer (relative hazard, 0.31; 95% CI, 0.10 to 0.96; P=0.04). ...
RESULTS: During a median of 34 months of treatment, the tibolone group, as compared with the placebo group, had a decreased risk of vertebra …
Androgens and breast cancer risk
Kenemans P and van der Mooren MJ. Gynecol Endocrinol 2012 - Review. PMID 22394304
CA 125: fundamental and clinical aspects
Verheijen RH, et al. Semin Cancer Biol 1999 - Review. Among authors: Kenemans P. PMID 10202133
303 results
Jump to page
Feedback